COMPOUNDS THAT INHIBIT PROTEASE CATHEPSIN S AND HCV REPLICATION
    2.
    发明申请
    COMPOUNDS THAT INHIBIT PROTEASE CATHEPSIN S AND HCV REPLICATION 失效
    抑制蛋白激酶S和HCV复制的化合物

    公开(公告)号:US20090270415A1

    公开(公告)日:2009-10-29

    申请号:US12256370

    申请日:2008-10-22

    IPC分类号: A61K31/497 C07D403/12

    CPC分类号: C07D403/12

    摘要: The present invention is directed to compounds that have the dual property of acting as cathepsin S inhibitors and of inhibiting HCV replication. Such compounds are therefore useful in treating disease states that include hepatitis C, Alzheimer's disease, and autoimmune disorders. The present invention is also directed to pharmaceutical compositions containing these compounds, and processes for preparing the compounds.

    摘要翻译: 本发明涉及具有作为组织蛋白酶S抑制剂和抑制HCV复制的双重性质的化合物。 因此,这样的化合物可用于治疗包括丙型肝炎,阿尔茨海默氏病和自身免疫性疾病的疾病状态。 本发明还涉及含有这些化合物的药物组合物及其制备方法。

    Alpha ketoamide compounds as cysteine protease inhibitors
    3.
    发明授权
    Alpha ketoamide compounds as cysteine protease inhibitors 有权
    α-酮酰胺化合物作为半胱氨酸蛋白酶抑制剂

    公开(公告)号:US07488848B2

    公开(公告)日:2009-02-10

    申请号:US11384023

    申请日:2006-03-17

    IPC分类号: C07C233/05 A61K31/65

    摘要: The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

    摘要翻译: 本发明涉及半胱氨酸蛋白酶,特别是组织蛋白酶B,K,L,F和S的抑制剂的化合物,因此可用于治疗由这些蛋白酶介导的疾病。 本发明涉及包含这些化合物的药物组合物及其制备方法。

    Peptidic compounds as cysteine protease inhibitors
    6.
    发明授权
    Peptidic compounds as cysteine protease inhibitors 有权
    肽类化合物作为半胱氨酸蛋白酶抑制剂

    公开(公告)号:US07101880B2

    公开(公告)日:2006-09-05

    申请号:US10603437

    申请日:2003-06-24

    IPC分类号: A61K31/535 C07D413/00

    摘要: The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

    摘要翻译: 本发明涉及半胱氨酸蛋白酶,特别是组织蛋白酶B,K,L,F和S的抑制剂的化合物,因此可用于治疗由这些蛋白酶介导的疾病。 本发明涉及包含这些化合物的药物组合物及其制备方法。